Welcome to our dedicated page for So-Young International SEC filings (Ticker: SY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
So-Young International Inc. filings document foreign-issuer reporting for a Nasdaq-listed ADS issuer operating in China’s aesthetic treatment market. The company’s Form 6-K reports furnish press releases on quarterly and annual operating results, including platform activity, aesthetic treatment services, branded aesthetic centers, user and visit metrics, and related financial performance.
The filing record also covers annual Form 20-F reporting, corporate governance changes, ADS and listing-status matters, and risk and operating disclosures tied to So-Young’s online services, offline treatment centers, medical equipment and injectable product activities.
So-Young International Inc. (NASDAQ: SY) submitted a Form 6-K to the U.S. Securities and Exchange Commission for the month of June 2025. The filing is strictly a current report by a foreign private issuer and contains one exhibit (99.1), identified only as a press release. No financial statements, earnings figures, or transaction details are included in the furnished documents. The report was signed on June 20, 2025 by Chief Financial Officer Hui Zhao.
The submission indicates routine compliance with Exchange Act Rules 13a-16 and 15d-16, serving to formally place the forthcoming press release in the SEC’s public record. Because the press release itself is not provided in this filing, investors receive no new quantitative or strategic information from this document alone.